TXMD Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Acquisition of TherapeuticsMD by EW Healthcare Partners
globenewswire.com
news
2022-05-31 00:00:00

MONSEY, N.Y., May 31, 2022 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of TherapeuticsMD (ticker: TXMD) ('TXMD') acted in the best interests of TXMD shareholders in approving the sale of TXMD to EW Healthcare Partners ('EWHP') for $10.00 per share in cash in a tender offer. If you remain a TXMD shareholder and have questions about your legal rights, you may contact our firm at the following link to discuss your options at no charge: https://wohlfruchter.
